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O’Brien and Stout firstly described Malignant fibrous
histiocytoma (MFH) in 1964 (1). MFH usually arises
from soft tissue of the extremities (more frequently in
the lower limb), the trunk and retroperitoneum (2). Ra-
rely, MFH may arise from abdominal or intestinal struc-
tures, with about 40 cases described in literature (3-7).
We report a case of a primary abdominal malignant
fibrous histiocytoma originating from the mesocolon
transversum.
Case report
A 79-year-old female patient was referred to the Department of
General Surgery of Uremic and Organ Transplantation with a non
tender, rubbery, palpable mass in the epigastrium and right hypo-
chondrium and normal skin, dyspepsia for one month. Laboratory
tests result normal except for haemoglobin (8.2 g/dL), red blood cel-
ls (3.06x199/L), sideraemia (22 µg/mL) and serum ferritin (579
ng/mL).
Ultrasonography showed, 1 cm under skin plane, a huge mass
at least 12 cm x 7 cm sized with mixed echotexture and poorly de-
finied borders, strictly close to the left hepatic lobe (Fig. 1). Endo-
scopy revealed compression of the posterior wall of the gastric an-
trum. A Computed Tomography (CT) scan of the abdomen showed
a huge and unomogeneously hypodense mass (15 cm) without cal-
cification. The mass showed unomogeneous contrast-enhancement,
after the injection of iodinated contrast agent, and was suspected ori-
ginating from the pancreas and infiltrating the left lobe of the liver.
Magnetic Resonance Imaging (MRI) confirmed the presence of a
15x11x6.7 cm retroperitoneal mass compressing and dislocating the
posterior gastric wall and depicted the presence of septa within the
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lesion, which also showed a thin but incomplete wall (Fig. 2). The
mass was markedly unomogeneous either before and after the injec-
tion of a Gadolinium-based contrast agent, with faint peripheral con-
trast-enhancement. Septa also showed contrast-enhancement, but
the lesion was substantially hypovascular (Fig. 3). Superior mesen-
teric artery was patent but dislocated laterally. No dilatation of in-
trahepatic and extrahepatic bile ducts or Wirsung was appreciable.
The mass did not show clear cleavage planes from the pancreas and
a mucin producing pancreatic tumor was first supposed. 
At surgery, a 15 cm sized mass, strictly adherent to the poste-
rior wall of gastric antrum, body and tail of the pancreas and me-
socolon transversum, was detached from the stomach and a left pan-
creasectomy with sparing of the spleen was performed. 
Macroscopic evaluation  reported a 14x14x6 cm tawny yellow
crumbly mass with a smooth capsule; at cut section a dense tissue
with large haemorrhagic areas, often cystic, was observed. Microscopic
evaluation showed a mixed cellular pattern, consisting of pleomorphic
cell elements presenting high grade nuclear atypia, large and pleo-
morphic nuclei, mitotic index 8/10 High Power Field (HPF), mul-
tinuclear giant cells (osteoclastic-like cells) and spindle-shaped cells.
The immunochemistry profile of tumor cells showed positivity
for vimentin and CD68 (PGM1), and negativity for S100 protein,
cytokeratin, desmin and actin (Fig. 4a). These findings were consi-
stent with a pathological diagnosis of malignant fibrous histiocyto-
ma (giant cell type) (Fig. 4b). Chronic pancreatitis was also patho-
logically diagnosed. 
Patient underwent a six month chemotherapy with gemcitabi-
ne. Positron Emission Tomography (PET) examination (88 MBq
of 18F-FDG), performed four months after surgery, revealed accu-
mulation of the radio-tracer in VII segment of the liver and in the
epigastrium consistent with still viable tumoral tissue as already
showed by CT follow-up. Twenty-one months after surgery the pa-
tient is under clinical follow-up.
Discussion
MFH usually occurs in the seventh decade of life pre-
senting as painless mass originating from fibroblasts of
soft tissues (5, 6). Histologically, five subtypes of MHH
are described: pleomorphic, storiform, myxoid, giant cell,
inflammatory and angiomatoid. The pleomorphic and
myxoid subtypes are more frequent and show a higher
grade of malignancy when compared with the other
subtypes. 
Primary abdominal or intestinal MHF are quite ra-
re and clinical symptoms are usually not specific and oc-
cur late despite MHF size may range from 2 up to 20
cm (3-6). Abdominal pain, dyspepsia, fever, diarrhea,
weight loss and, ultimately, a palpable abdominal mass
Fig. 1 - Ultrasound examination shows a large mass with mixed echotexture
and poorly defined borders.  
Fig. 2 - T2-weighted FSE MR image depicts a huge multiloculated abdominal
tumour with unomogeneous and high signal intensitym, bounded by thin hy-
pointense capsule (arrows).  
Fig. 3 - At contrast-enhanced GRE T1-weighted image the mass shows a
moderate and heterogeneous uptake of contrast medium mainly at the pe-
riphery and within the septa (arrow) and dislocates the stomach  on the left
(arrowheads).
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are often described. Our patient had a huge palpable ab-
dominal mass dislocating adjacent organs, such as sto-
mach and liver. The patient also complained of anorexia
and dyspepsia. A microcytic hypochromic anemia with
increased serum level of ferritin was also present.
MHF are difficult to diagnose and do not show spe-
cific imaging findings (8). According to literature data
and our experience, ultrasound examination may show
a hypoechoic, mixed (because of tumoral necrosis) or ane-
choic pattern with internal hyperechoic septa (9, 10).
CT usually depicts MFH either as well or ill defined
mass, with attenuation values similar or slightly lower
than normal muscle. Hypodense areas within the mass
may be appreciable owing to necrosis or haemorrhagic
infarction (9-12). In about 16% of abdominal MFH,
especially pleomorphic, CT may demonstrate the pre-
sence of peripheral calcifications (12). MHF may inva-
de adjacent organs, such as bowel, pancreas and kidney,
making difficult to ascertain the precise site from whi-
ch the mass originates (11). 
In our case neither US nor contrast-enhanced CT
was able to make a precise diagnosis. MRI concluded
for a suspected cystic neoplasm of the pancreas. Cystic
appearance of MFH has been reported, sometimes be-
cause of bleeding within the lesion (11, 13-16). Hen-
ce, anemia may occur, as in our patient, who had mi-
crocytic hypochromic anemia with increased serum le-
vel of ferritin. All imaging modalities showed a close re-
lationship between the mass and the left hepatic lobe,
but laparotomy ruled out any invasion of the liver. Hi-
stology with immunohistochemistry demonstrated a pri-
mary abdominal malignant fibrous histiocytoma origi-
nating from the mesocolon transversum. 
Conclusion
Primary abdominal MFHs are rare and biologically
aggressive malignancies. Differential diagnosis must in-
clude cystic neoplasms of the pancreas (mucinous and
serous cystoadenoma or cystocarcinoma), cystic
lymphangioma or mesothelioma and retroperitoneal hae-
matoma. Making the right diagnosis preoperatively may
be often difficult, but MFH may be suspected when a
huge retroperitoneal mass is found at imaging in elderly
patients. 
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Fig. 4 - A) Vimentin immunohistochemistry staining shows a diffuse and intense positivity of the majority of the neoplastic cells, while giant multinucleated cells
prove negative (magnification 200x). B) The giant multinuclear cell component of the tumor stains positive for CD68 immunohistochemistry reaction (magnifica-
tion 200x).
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